RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재

    정신분열병 환자의 비정형 항정신병약물 반응과 세로토닌 2A 및 도파민 D3 수용체 유전자 다형성의 관련연구

    한글로보기

    https://www.riss.kr/link?id=A105321661

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
      • URL 복사
    • 오류접수
    인용문이 복사되었습니다.

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    Objectives:This study was performed based on the hypothesis that the interindividual differences
    in clinical response to atypical antipsychotics might be associated with serotonin 2A receptor(5-HT2A)
    gene and(or) dopamine D3 receptor(DRD3) gene polymorphisms.
    Methods:Seventy-five patients(39 men, 36 women) who met DSM-IV criteria for Schizophrenia at
    the Asan Medical Center were selected for the analysis of the medical records and subsequent interview.
    A written informed consent was obtained prior to the study and the privacy protection was kept throughout
    the course. Clinical Global Impression(CGI) Scale was applied after 4 weeks of treatment to assess
    the response to atypical antipsychotics. All patients in this study were administered olanzapine(n=39),
    risperidone(n=52) or clozapine(n=4). According to CGI scale, the patients were classified in 7 groups;
    very much improvement;much improvement;minimal improvement;no change;minimal worsening;
    much worsening;very much worsening. The first and second groups were regarded as responders
    while the other groups were non-responders. Patients were genotyped for 5-HT2A by PCR(Msp
    I) for detection of T102 and C102 alleles. And they were also genotyped for DRD3 Ser9Gly polymorphism
    by PCR(Bal I). We conducted the statistical analyses to detect association between responders and non
    responders with chi-square tests.
    Results:The patients who were shown no or minimally improved patients were sorted to nonresponders(
    n=42, men 24, women 18) and the other patients shown much or very much improved were
    grouped as responders(n=33, men 15, women 18). The differences in demographic variables(age, sex),
    age of onset, and duration of illness were not statistically significant between the two groups. T102
    allele is more frequent in non-responders(56.0%) than responders(45.5%), however, this difference
    is not statistically significant(p=0.20). Gly9 allele is near equal between non-responders and responders
    (65.5%, 65.2%). Genotype frequencies of the two groups also is not a statistically significant for 5-
    HT2A T102C(p=0.28) and DRD3 Ser9Gly(p=0.90).
    Conclusion:These results do not show significant associations among 5-HT2A gene, DRD3 gene
    and clinical response to atypical antipsychotics. On the assumption that responses to atypical antipsychotics
    are mediated by these two receptors, we can draw two possibilities. First, 5-HT2A and DRD3 genes may
    not be the functional variants related with responses to atypical antipsychotics. Second possibility is
    that the unknown variations which might be in linkage disequilibrium with the 5-HT2A T102C polymorphism
    and DRD3 Ser9Gly polymorphism may be associated with the response to atypical antipsychotics
    in schizophrenia. However, it is possible that the small number of subjects and ethnic difference of allele
    frequency of marker polymorphism could induce false negative results.
    번역하기

    Objectives:This study was performed based on the hypothesis that the interindividual differences in clinical response to atypical antipsychotics might be associated with serotonin 2A receptor(5-HT2A) gene and(or) dopamine D3 receptor(DRD3) gene poly...

    Objectives:This study was performed based on the hypothesis that the interindividual differences
    in clinical response to atypical antipsychotics might be associated with serotonin 2A receptor(5-HT2A)
    gene and(or) dopamine D3 receptor(DRD3) gene polymorphisms.
    Methods:Seventy-five patients(39 men, 36 women) who met DSM-IV criteria for Schizophrenia at
    the Asan Medical Center were selected for the analysis of the medical records and subsequent interview.
    A written informed consent was obtained prior to the study and the privacy protection was kept throughout
    the course. Clinical Global Impression(CGI) Scale was applied after 4 weeks of treatment to assess
    the response to atypical antipsychotics. All patients in this study were administered olanzapine(n=39),
    risperidone(n=52) or clozapine(n=4). According to CGI scale, the patients were classified in 7 groups;
    very much improvement;much improvement;minimal improvement;no change;minimal worsening;
    much worsening;very much worsening. The first and second groups were regarded as responders
    while the other groups were non-responders. Patients were genotyped for 5-HT2A by PCR(Msp
    I) for detection of T102 and C102 alleles. And they were also genotyped for DRD3 Ser9Gly polymorphism
    by PCR(Bal I). We conducted the statistical analyses to detect association between responders and non
    responders with chi-square tests.
    Results:The patients who were shown no or minimally improved patients were sorted to nonresponders(
    n=42, men 24, women 18) and the other patients shown much or very much improved were
    grouped as responders(n=33, men 15, women 18). The differences in demographic variables(age, sex),
    age of onset, and duration of illness were not statistically significant between the two groups. T102
    allele is more frequent in non-responders(56.0%) than responders(45.5%), however, this difference
    is not statistically significant(p=0.20). Gly9 allele is near equal between non-responders and responders
    (65.5%, 65.2%). Genotype frequencies of the two groups also is not a statistically significant for 5-
    HT2A T102C(p=0.28) and DRD3 Ser9Gly(p=0.90).
    Conclusion:These results do not show significant associations among 5-HT2A gene, DRD3 gene
    and clinical response to atypical antipsychotics. On the assumption that responses to atypical antipsychotics
    are mediated by these two receptors, we can draw two possibilities. First, 5-HT2A and DRD3 genes may
    not be the functional variants related with responses to atypical antipsychotics. Second possibility is
    that the unknown variations which might be in linkage disequilibrium with the 5-HT2A T102C polymorphism
    and DRD3 Ser9Gly polymorphism may be associated with the response to atypical antipsychotics
    in schizophrenia. However, it is possible that the small number of subjects and ethnic difference of allele
    frequency of marker polymorphism could induce false negative results.

    더보기

    동일학술지(권/호) 다른 논문

    동일학술지 더보기

    더보기

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2023 평가 재인증평가 신청대상 (재인증)
    2020-01-01 등재 등재학술지 선정 (재인증) KCI등재
    2018-01-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    2016-12-01 등재 등재후보 탈락 (계속평가)
    2015-12-01 등재 등재후보로 하락 (기타) KCI등재후보
    2011-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2009-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2006-01-01 등재 등재학술지 선정 (등재후보2차) KCI등재
    2005-01-01 등재 등재후보 1차 PASS (등재후보1차) KCI등재후보
    2003-01-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기
    해외이동버튼